VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 61 filers reported holding VERSARTIS INC in Q2 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $86,000 | -25.2% | 52,148 | 0.0% | 0.00% | – |
| Q4 2017 | $115,000 | -10.2% | 52,148 | 0.0% | 0.00% | – |
| Q3 2017 | $128,000 | -87.3% | 52,148 | -9.8% | 0.00% | -100.0% |
| Q2 2017 | $1,009,000 | -23.4% | 57,795 | -6.3% | 0.00% | -33.3% |
| Q1 2017 | $1,317,000 | +37.0% | 61,695 | -4.3% | 0.00% | +50.0% |
| Q4 2016 | $961,000 | +35.7% | 64,495 | +11.6% | 0.00% | +100.0% |
| Q3 2016 | $708,000 | +11.7% | 57,795 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $634,000 | +66.0% | 57,295 | +20.2% | 0.00% | 0.0% |
| Q1 2016 | $382,000 | -26.1% | 47,663 | +14.2% | 0.00% | 0.0% |
| Q4 2015 | $517,000 | +9.3% | 41,734 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $473,000 | -24.3% | 40,986 | -0.2% | 0.00% | -50.0% |
| Q2 2015 | $625,000 | +120.8% | 41,086 | +166.3% | 0.00% | +100.0% |
| Q1 2015 | $283,000 | -1.7% | 15,428 | +20.3% | 0.00% | 0.0% |
| Q4 2014 | $288,000 | +18.5% | 12,828 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $243,000 | -31.7% | 12,773 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $356,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |